tiprankstipranks
Advanced BioMedical Technologies Inc. (ABMT)
OTHER OTC:ABMT
US Market

Advanced BioMedical Technologies (ABMT) Financial Statements

10 Followers

Advanced BioMedical Technologies Financial Overview

Advanced BioMedical Technologies's market cap is currently $50.00K. The company's EPS TTM is $-0.007; its P/E ratio is -0.07; Advanced BioMedical Technologies is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 22Oct 21Oct 20Oct 19Oct 18
Income Statement
Total Revenue$ 270.99K$ 171.19K$ 123.59K$ 11.66K$ 0.00
Gross Profit$ 221.88K$ 93.30K$ 71.77K$ 4.06K$ 0.00
Operating Income$ -179.88K$ -394.86K$ -446.62K$ -604.74K$ -634.02K
EBITDA$ -166.01K$ -367.44K$ -282.69K$ -601.26K$ -636.46K
Net Income$ -515.49K$ -729.44K$ -672.00K$ -948.82K$ -953.32K
Balance Sheet
Cash & Short-Term Investments$ 4.84K$ 36.98K$ 201.66K$ 5.59K$ 6.86K
Total Assets$ 395.70K$ 448.66K$ 469.23K$ 218.50K$ 142.40K
Total Debt$ 6.81M$ 6.89M$ 4.74M$ 4.92M$ 4.33M
Net Debt$ 6.81M$ 6.85M$ 4.54M$ 4.91M$ 4.32M
Total Liabilities$ 8.33M$ 8.83M$ 7.87M$ 6.70M$ 5.76M
Stockholders' Equity$ -7.94M$ -8.38M$ -7.40M$ -6.48M$ -5.62M
Cash Flow
Free Cash Flow$ -734.53K$ -897.14K$ 615.95K$ -761.10K$ -896.83K
Operating Cash Flow$ -734.53K$ -845.61K$ 646.66K$ -742.53K$ -832.42K
Investing Cash Flow$ 0.00$ -51.53K$ -30.71K$ -18.57K$ -64.41K
Financing Cash Flow$ 703.95K$ 725.69K$ -427.82K$ 759.84K$ 896.28K
Currency in USD

Advanced BioMedical Technologies Earnings and Revenue History

Advanced BioMedical Technologies Debt to Assets

Advanced BioMedical Technologies Cash Flow

Advanced BioMedical Technologies Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.